E-LIB Suche - Ergebnisse für: Paz-Ares, L.

1

11P Patritumab deruxtecan (HER3-DXd) in previously treated ..:

Hayashi, H. ; Goto, Y. ; Yu, H.A....
ESMO Open. 9 (2024) - p. 102590 , 2024

Link: https://doi.org/10.1016/..

2

195MO Tarlatamab in previously treated small cell lung canc..:

Hummel, H-D. ; Champiat, S. ; Garcia, M.E. Olmedo...
ESMO Open. 9 (2024) - p. 102768 , 2024

Link: https://doi.org/10.1016/..

3

104TiP Phase Ib/IIa study of ATR inhibitor tuvusertib + ant..:

Paz-Ares, L. ; Cappuzzo, F. ; Yamamoto, N....
ESMO Open. 9 (2024) - p. 102683 , 2024

Link: https://doi.org/10.1016/..

4

63P Treatment-free survival (TFS) in patients (pts) with mN..:

Reck, M. ; Regan, M. ; Carbone, D.P....
ESMO Open. 9 (2024) - p. 102642 , 2024

Link: https://doi.org/10.1016/..

5

7P Patient-relevant endpoints from PAPILLON: Amivantamab pl..:

Paz-Ares, L. ; Veillon, R. ; Majem, M....
ESMO Open. 9 (2024) - p. 102586 , 2024

Link: https://doi.org/10.1016/..

6

214TiP Tarlatamab after chemoradiotherapy in limited-stage ..:

Hummel, H-D. ; Paz-Ares, L. ; Blackhall, F....
ESMO Open. 9 (2024) - p. 102787 , 2024

Link: https://doi.org/10.1016/..

7

59P Datopotamab deruxtecan (Dato-DXd) in patients with prev..:

Girard, N. ; Okamoto, I. ; Lisberg, A.E....
ESMO Open. 9 (2024) - p. 102638 , 2024

Link: https://doi.org/10.1016/..

8

P1.23-08 Clinical Utility of Combined Plasma and Tissue NGS..:

Bote de Cabo, H. ; Siringo, M. ; García-Lorenzo, E....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S258 , 2023

Link: https://doi.org/10.1016/..

9

P2.16-06 A Phase 2 Study of Ifinatamab Deruxtecan (I-DXd; D..:

Rudin, C. ; Johnson, M. ; Girard, N....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S377 , 2023

Link: https://doi.org/10.1016/..

10

P2.06-09 Association of Clinical Response and HRQoL with Lo..:

Reck, M. ; Worthy, G. ; Yuan, Y....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S320-S321 , 2023

Link: https://doi.org/10.1016/..

11

13MO Safety and efficacy of tusamitamab ravtansine in combi..:

Isambert, N. ; Nagy, T. ; Ravoire, M....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S46-S47 , 2023

Link: https://doi.org/10.1016/..

12

165P SCLC subtypes are associated with distinct dinicopatho..:

Rocha, P. ; Sanchez, I. ; Pinto, L. Masfarre...
Journal of Thoracic Oncology. 18 (2023) 4 - p. S131 , 2023

Link: https://doi.org/10.1016/..

13

OA14.05 5-Year Survival of Pembrolizumab Plus Chemotherapy ..:

Gadgeel, S. ; Rodríguez-Abreu, D. ; Halmos, B....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S77-S78 , 2023

Link: https://doi.org/10.1016/..

14

P2.17-06 Efficacy of Platinum after Lurbinectedin + DOX or ..:

Navarro, A. ; Smit, E. ; Carcereny, E....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S380-S381 , 2023

Link: https://doi.org/10.1016/..

15

Pathologist-initiated reflex testing for biomarkers in non-..:

Gosney, J.R. ; Paz-Ares, L. ; Jänne, P....
ESMO Open. 8 (2023) 4 - p. 101587 , 2023

Link: https://doi.org/10.1016/..